INTS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.137200E-01
Normal-vs-Stage2
4.813200E-01
Normal-vs-Stage3
2.098800E-01
Normal-vs-Stage4
4.283800E-01
Stage1-vs-Stage2
2.850800E-01
Stage1-vs-Stage3
8.187700E-02
Stage1-vs-Stage4
5.290400E-01
Stage2-vs-Stage3
6.576200E-02
Stage2-vs-Stage4
9.672600E-01
Stage3-vs-Stage4
7.865900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.321800E-01
Normal-vs-AfricanAmerican
8.805800E-02
Normal-vs-Asian
5.307000E-01
Caucasian-vs-AfricanAmerican
1.260560E-01
Caucasian-vs-Asian
7.956400E-01
AfricanAmerican-vs-Asian
3.119400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.571200E-01
Normal-vs-Female
5.744200E-01
Male-vs-Female
3.126400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.840800E-01
Normal-vs-Age(41-60Yrs)
3.543600E-01
Normal-vs-Age(61-80Yrs)
6.051800E-01
Normal-vs-Age(81-100Yrs)
3.188800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.593160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.341200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.703190E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.187800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.757400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.339000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.598000E-01
Normal-vs-Daily Drinker
9.005200E-01
Normal-vs-Weekly Drinker
5.026600E-01
Normal-vs-Occasional Drinker
4.055000E-01
Normal-vs-Social Drinker
5.565400E-01
Non Drinker-vs-Daily Drinker
2.298200E-01
Non Drinker-vs-Weekly Drinker
5.578800E-01
Non Drinker-vs-Occasional Drinker
4.110400E-01
Non Drinker-vs-Social Drinker
6.222200E-01
Daily Drinker-vs-Weekly Drinker
1.276560E-01
Daily Drinker-vs-Occasional Drinker
6.280300E-02
Daily Drinker-vs-Social Drinker
1.580200E-01
Weekly Drinker-vs-Occasional Drinker
8.962000E-01
Weekly Drinker-vs-Social Drinker
9.436600E-01
Occasional Drinker-vs-Social Drinker
8.354800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.710800E-01
Normal-vs-Grade 2
8.509800E-01
Normal-vs-Grade 3
7.707400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.686800E-01
Grade 1-vs-Grade 3
2.080200E-01
Grade 1-vs-Grade 4
6.710800E-01
Grade 2-vs-Grade 3
1.416610E-01
Grade 2-vs-Grade 4
8.509800E-01
Grade 3-vs-Grade 4
7.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.208600E-01
Normal-vs-NonDiabetic
5.270400E-01
Diabetic-vs-NonDiabetic
2.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.718600E-01
Normal-vs-NoPancreatitis
5.872200E-01
Pancreatitis-vs-NoPancreatitis
3.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.746400E-01
Normal-vs-N1
5.036600E-01
N0-vs-N1
7.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.490980E-01
Normal-vs-TP53-NonMutant
2.307400E-01
TP53-Mutant-vs-TP53-NonMutant
4.739800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
